Related Experiment Video
Updated: Feb 3, 2026
05:21
Establishment of A Mouse Model of Aqueous Deficiency Dry Eye
Published on: November 1, 2024
1.4K
PACAP deficiency as a model of aging
D Reglodi1, T Atlasz2,3, E Szabo2
1Department of Anatomy, MTA-PTE PACAP Research Group, University of Pecs Medical School, Pecs, Hungary. dora.reglodi@aok.pte.hu.
Geroscience
|October 23, 2018
Summary
Pituitary adenylate cyclase-activating polypeptide (PACAP) deficiency accelerates aging. PACAP knockout mice exhibit premature aging signs, suggesting PACAP’s crucial role in mitigating age-related degeneration.
Area of Science:
- Neuroscience
- Aging Research
- Molecular Biology
Background:
- Neuropeptide dysregulation is implicated in aging.
- Pituitary adenylate cyclase-activating polypeptide (PACAP) is a cytoprotective peptide with neuroprotective, anti-apoptotic, anti-inflammatory, and antioxidant effects.
- PACAP is part of the body's natural defense against tissue damage.
Purpose of the Study:
- To investigate the role of endogenous PACAP in age-related degeneration.
- To determine if PACAP deficiency accelerates aging processes.
- To evaluate PACAP knockout mice as a model for premature aging.
Main Methods:
- Review of existing research on PACAP and aging.
- Analysis of studies involving PACAP deficiency and its effects.
- Comparison of pathological alterations in PACAP-deficient mice with age-related changes.
Main Results:
- PACAP deficiency mimics age-related pathophysiological changes.
- PACAP knockout mice show increased neuronal vulnerability, systemic degeneration, apoptosis, oxidative stress, and inflammation.
- Specific age-mimicking alterations include retinal changes, corneal keratinization, and amyloidosis.
Conclusions:
- PACAP deficiency accelerates age-related degeneration.
- PACAP knockout mice serve as a valuable model for studying premature aging.
- Maintaining adequate PACAP levels may be crucial for healthy aging.
Related Concept Videos
01:26Aging
703
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
703
01:19The Effect of Aging on Tissues
3.5K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.5K
01:09Changes in the Appendicular Skeleton with Age
3.5K
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.5K
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
237
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
237
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
701
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
701
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
261
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
261